These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8363214)

  • 1. Rapamycin's inhibition of thymocyte proliferation, unlike that of cyclosporin A or prednisolone, is not associated with cytotoxicity.
    Bansbach CC; Wancio D; Caccese RG; Shen CF; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():114-6. PubMed ID: 8363214
    [No Abstract]   [Full Text] [Related]  

  • 2. Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays.
    Ferron GM; Jusko WJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):191-200. PubMed ID: 9655860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation.
    Olivera DL; Kaplan JM; Newman-Tarr T; Ruggieri EV; Badger AM
    Clin Immunol Immunopathol; 1993 Sep; 68(3):357-62. PubMed ID: 7690317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 5. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
    Mattila PS
    Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
    Pockley AG; Williams S; Reid SD; Bowles MJ
    Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapamycin inhibits lymphocyte proliferation in a popliteal lymph node model via an IL-2-independent mechanism.
    Warner LM; Lewis GM; Weichman BM; Sehgal SN
    Ann N Y Acad Sci; 1993 Jun; 685():117-20. PubMed ID: 8363215
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.
    Ferron GM; Pyszczynski NA; Jusko WJ
    Transplantation; 1998 May; 65(9):1203-9. PubMed ID: 9603169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of cyclosporin-A and rapamycin on in vivo thymocyte maturation.
    Homma M; Damoiseaux JG; van Breda Vriesman PJ
    Transplant Proc; 1997 May; 29(3):1743-4. PubMed ID: 9142256
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapamycin.
    Carlson RP; Sehgal SN; Lewis AJ
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
    Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
    Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
    Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.
    Böhler T; Waiser J; Budde K; Lichter S; Jauho A; Fritsche L; Korn A; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2195-7. PubMed ID: 9723438
    [No Abstract]   [Full Text] [Related]  

  • 16. A modification of the in vivo mixed lymphocyte reaction and rapamycin's effect in this model.
    Warner LM; Adams LM; Chang JY; Sehgal SN
    Clin Immunol Immunopathol; 1992 Sep; 64(3):242-7. PubMed ID: 1386564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of sirolimus on cytokine dependent and cytokine independent proliferation.
    Molnar-Kimber KL; Rhoad A; Warner L; Chen H; Sehgal SN
    Inflamm Res; 1995 Aug; 44 Suppl 2():S189-90. PubMed ID: 8548391
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation.
    Mollison KW; Fey TA; Krause RA; Thomas VA; Mehta AP; Luly JR
    Ann N Y Acad Sci; 1993 Jun; 685():55-7. PubMed ID: 7689812
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
    Combates NJ; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.